Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H7ClN2O4S2 |
Molecular Weight | 270.714 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(=O)(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
InChI
InChIKey=NENBAISIHCWPKP-UHFFFAOYSA-N
InChI=1S/C6H7ClN2O4S2/c7-5-2-1-4(14(8,10)11)3-6(5)15(9,12)13/h1-3H,(H2,8,10,11)(H2,9,12,13)
Molecular Formula | C6H7ClN2O4S2 |
Molecular Weight | 270.714 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/uk/pdf/leaflet/725899.pdfCurator's Comment: Description was created based on several sources, including https://www.drugs.com/international/clofenamide.html and https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C77559
Sources: https://www.drugs.com/uk/pdf/leaflet/725899.pdf
Curator's Comment: Description was created based on several sources, including https://www.drugs.com/international/clofenamide.html and https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C77559
Clofenamide is a benzenedisulfonamide-based agent and carbonic anhydrase (CA) inhibitor with diuretic activity. Clofenamide inhibits CA, thereby preventing sodium, bicarbonate and thus water reabsorption in the proximal convoluted tubule resulting in diuresis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095180 Sources: http://www.genome.jp/dbget-bin/www_bget?D01822 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Aponiere Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Electron-capture GLC assay of dichlorphenamide. | 1979 Mar |
|
The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine. | 1986 Sep |
|
Biopharmaceutical studies of thiazide diuretics. III. In vivo formation of 2-amino-4-chloro-m-benzenedisulfonamide as a metabolite of hydrochlorothiazide in a patient. | 1987 Aug |
|
Binding of 2-amino-4-chloro-m-benzenedisulfonamide as a metabolite of hydrochlorothiazide to erythrocytes. | 1990 Oct |
|
[X-ray structural analysis of kidney stones. Mechanism of action of pharmalith in nephrolithiasis]. | 1998 Nov-Dec |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:47:16 GMT 2023
by
admin
on
Sat Dec 16 17:47:16 GMT 2023
|
Record UNII |
582ILN204B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C03BA07
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
||
|
NCI_THESAURUS |
C448
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
||
|
WHO-ATC |
C03BB07
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
||
|
WHO-VATC |
QC03BA07
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
||
|
WHO-VATC |
QC03BB07
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1865258
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
SUB06697MIG
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
C77559
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
693
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
DB13663
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
671-95-4
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
211-588-5
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
1396
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
582ILN204B
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
100000084290
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
69594
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
CLOFENAMIDE
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
DTXSID4046153
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | |||
|
m1078
Created by
admin on Sat Dec 16 17:47:16 GMT 2023 , Edited by admin on Sat Dec 16 17:47:16 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |